Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: The framingham study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 5, 2000, Pages 1323-1329

  Ordovas, Jose M ^a   Cupples, L Adrienne ^b   Corella, Dolores ^a   Otvos, James D ^c   Osgood, Doreen ^a   Martinez, Antonia ^a   Lahoz, Carlos ^a   Coltell, Oscar ^a   Wilson, Peter W F ^d   Schaefer, Ernst J ^a  

^a TUFTS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cholesteryl ester transfer protein; Coronary heart disease; Gene polymorphisms; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; INTRON; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; REGRESSION ANALYSIS; RISK; SEX DIFFERENCE;

EID: 0034061148     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.5.1323     Document Type: Article

References (50)

1. Drayna D, Jarnagin AS, McLean J, Henzel W. Kohr W, Fielding C, Lawn R. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature. 1987;327:632-634.
2. Bruce C, Chouinard RA Jr, Tall AR. Plasma lipid transfer proteins, high density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr. 1998; 18:297-330.
3. Yamashita S, Sakai N, Hirano K, Arai T, Ishigami M, Maruyama T, Matsuzawa Y. Molecular genetics of plasma cholesteryl ester transfer protein. Curr Opin Lipidol. 1997;8:101-110.
4. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med. 1990;323:1234-1238.
5. Koizumi J, Inazu A, Yagi K, Koizumi I, Uno Y, Kajinami K, Miyamoto S, Moulin P, Tall AR, Mabuchi H. Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. Atherosclerosis. 1991;90: 189-196.
6. Takegoshi T, Haba T, Kitoh C, Inazu A, Koizumi J, Mabuchi H, Takeda R. Compound heterozygote of cholesteryl-ester transfer protein deficiency in a patient with hyperalphalipoproteinemia. Atherosclerosis. 1992;96:83-85.
7. Inazu A, Jiang X-C, Haraki T, Yagi K, Kamon N, Koizumi J, Mabuchi H, Takeda R, Takata K, Moriyama Y. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest. 1994;94:1872-1882.
8. Hill SA, Nazir DJ, Jayaratne P, Bamford KS, McQueen MJ. Mutations in cholesteryl ester transfer protein and hepatic lipase in a North American population. Clin Biochem. 1997;30:413-418.
9. Tamminen M Kakko S, Kesäniemi YA, Savolainen MJ. A polymorphic site in the 3′ untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity. Atherosclerosis. 1996;124:237-247.
10. Drayna D, Lawn R. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res. 1987;15:4698.
11. Freeman D, Shepherd J, Packard CJ, Humphries SE, Gaffney D. An StuI RFLP at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res. 1989;17:2880.
12. Zuliani G, Hobbs HH. EcoNI polymorphism in the human cholesteryl ester transfer protein (CETP) gene. Nucleic Acids Res. 1990;18:2834.
13. Kondo I, Berg K, Drayna DT, Lawn RM. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet. 1989;35:49-56.
14. Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ, Shepherd J. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb. 1994;14:336-344.
15. Hannuksela ML, Liinamaa MJ, Kesäniemi YA, Savolainen MJ. Relation of polymorphisms in the cholesteryl ester-transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis. 1994;110:35-44.
16. Kuivenhoven JA, de Knijff P, Boer JMA, Smalheer HA, Botma GJ, Seidell JC, Kastelein JJ, Pritchard PH. Heterogeneity at the CETP gene locus: influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol. 1997;17:560-568.
17. Tenkanen H, Koskinen P, Kontula K, Aalto-Setälä K, Mänttän M, Manninen V, Runeberg SL, Taskinen MR, Ehnholm C. Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet. 1991;87:574-578.
18. Mitchell RJ Earl L, Williams J, Bisucci T, Gasiamis H. Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia. Hum Biol. 1994; 66:13-25.
19. Fumeron F, Betoulle D, Luc G, Behague I, Ricard B, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest. 1995;96:1664-1671.
20. Kauma H, Savolainen MJ, Heikkilä R, Rantala AO, Lilja M, Reunanen A, Kesaniemi YA. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet. 1996;97:156-162.
21. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI, Kastelein JJ. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis: the Regression Growth Evaluation Statin Study Group. N Engl J Med. 1998;338:86-93.
22. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med. 1977;62:707-714.
23. Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med. 1989:321:1311-1316.
24. Manninen V, Elo MO, Frick MH, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA. 1988;260:641-651.
25. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study: design and preliminary data. Prev Med. 1975;4:518-525.
26. Kannel WB Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol. 1979;110:281-290.
27. Dawber TR, Meadors GF, Moore R. Epidemiological approaches to heart disease: The Framingham Study. Am J Public Health. 1951;41:279-286.
28. Cupples LA, Gagnon DR, Kannel WB. Long-and short-term risk of sudden coronary death. Circulation. 1992;85:111-118.
29. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982:28:1379-1388.
30. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
31. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and apolipoprotein fractions. Clin Chim Acta. 1987; 166:1-9.
32. Schaefer EJ, Ordovas JM. Metabolism of the apolipoproteins A-I, A-II, and A-IV In: Segrest J, Albers J, ed. Methods in Enzymology, Plasma Lipoproteins, Part B: Characterization, Cell Biology and Metabolism. New York, NY: Academic Press; 1986:420-442.
33. Ordovas JM, Peterson JP, Santaniello P, Cohn J, Wilson PWF, Schaefer EJ. Enzyme linked immunosorbent assay for human apolipoprotein B. J Lipid Res. 1987;28:1216.
34. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single rapid measurement. Clin Chem. 1992;38:1632-1638.
35. Otvos JD. Measurement of lipoprotein subclass profile by nuclear magnetic resonance. In: Rifai N, Warnick GR, Dominiczak MH, ed. Handbook of Lipoprotein Testing. Washington. DC: AACC Press; 1997: 497-508.
36. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1989; 16:1215.
37. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31: 545-548.
38. Boerwinkle E, Utermann G. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet. 1988;42:104-112.
39. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-1211.
40. Bernard S, Moulin P, Lagrost L, Picard S, Elchebly M, Ponsin G, Chapuis F, Berthezene F. Association between plasma HDL-cholesterol concentration and TaqIB CETP gene polymorphism in non-insulm-dependent diabetes mellitus. J Lipid Res. 1998;39:59-65.
41. Freeman D, Packard CJ, Shepherd J, Gaffney D. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high density lipoprotein cholesterol and transfer ester activity. Clin Sci. 1990;79:575-581.
42. Gudnason V, Kakko S, Nicaud V, Savolainen MJ, Kesaniemi YA, Thavanainen E, Humphries S. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high density lipoprotein in European populations. Eur J Clin Invest. 1999;29:116-128.
43. Fielding CG, Havel RJ. Cholesteryl ester transfer protein: friend or foe? J Clin Invest 1996;97:2687-2688.
44. Stevenson CG. Cholesterol ester transfer protein: a molecule with three faces? Crit Rev Clin Lab Sci. 1998;35:517-546.
45. Jiang XC, Agellon LB, Walsh A, Breslow JL, Tall A. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice: dependence on natural flanking sequences. J Clin Invest. 1992;90:1290-1295.
46. Brunzell JD, Hokanson JE. Low-density and high-density lipoprotein subspecies and risk for premature coronary artery disease. Am J Med. 1999;107:16S-18S.
47. Tailleux A, Fruchart JC. HDL heterogeneity and atherosclerosis. Crit Rev Clin Lab Sci. 1996;33:163-201.
48. Roheim PS, Asztalos BF. Clinical significance of lipoprotein size and risk for coronary atherosclerosis. Clin Chem. 1995;41:147-152.
49. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglycerides, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882-888.
50. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996;276:875-881.